Speaker illustration

Professor David Morrow

Brigham and Women's Hospital, Boston (United States of America)

Member of:

European Society of Cardiology

David A. Morrow, MD, MPH is a Professor of Medicine at Harvard Medical School, the Section Head of Critical Care Cardiology, and the Director of the Samuel A. Levine Cardiac Intensive Care Unit in the Division of Cardiovascular Medicine at Brigham and Women’s Hospital. Dr. Morrow earned his medical degree from Harvard Medical School and a Masters in Public Health with a concentration in clinical study design and interpretation from the Harvard School of Public Health. Dr. Morrow is a Senior Investigator in the Thrombolysis in Myocardial Infarction Study Group at Brigham and Women’s Hospital with a research focus in the management of unstable and stable ischemic heart disease, as well as cardiac critical care, and he directs the TIMI Biomarker Program.

Different aspects of acute coronary syndromes, myocardial infarction related cardiogenic shock and cardiac arrest

Event: ESC Congress 2023

Topic: Cardiac Care Unit (CCU), Intensive, and Critical Cardiovascular Care

Session type: Moderated ePosters


Cardiogenic shock: state of the art 2022

Event: ESC Acute CardioVascular Care 2022

Topic: Cardiogenic Shock

Session type: Symposium


All you need to know about ventilation in the acute cardiovascular patient.

Event: ACVC 2021

Topic: Acute Cardiac Care

Session type: Symposium


Biomarker-based approaches for improved atrial fibrillation management

Event: ESC Congress 2018

Topic: Atrial Fibrillation (AF)

Session type: Satellite Symposium


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb